Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Andrew, Zelenetz"'
Autor:
Meng-Lei Zhu, Esther Drill, Erel Joffe, Gilles Salles, Alfredo Rivas Delgado, Andrew Zelenetz, Maria Lia Palomba, Maria Arcila, Ahmet Dogan
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/4ae2b25a30da4667960de18b75dde3b9
Autor:
Paola Ghione, Salma Ahsanuddin, Efrat Luttwak, Sabela Bobillo Varela, Reiko Nakajima, Laure Michaud, Kanika Gupta, Anastasia Navitski, David Straus, M. Lia Palomba, Alison Moskowitz, Ariela Noy, Paul Hamlin, Matthew Matasar, Anita Kumar, Lorenzo Falchi, Joachim Yahalom, Steven Horwitz, Andrew Zelenetz, Anas Younes, Gilles Salles, Heiko Schöder, Erel Joffe
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Osseous involvement by diffuse large B-cell lymphoma (DLBCL-bone) is a heterogeneous disease. There is limited data regarding response assessment by positron emission tomography with fluorodeoxyglucose, which may demonstrate residual avidity despite
Externí odkaz:
https://doaj.org/article/935b45e9aad94c84a0ba5650e34c9be6
Autor:
Manik Uppal, Connie Lee Batlevi, Lorenzo Falchi, Paul Hamlin, Steven Horwitz, Anita Kumar, Ariela Noy, Andrew Zelenetz, Maria Arcila, Ahmet Dogan, Brandon Imber, Joachim Yahalom, Gilles Salles, Erel Joffe
Publikováno v:
HemaSphere, Vol 7, p e465205e (2023)
Externí odkaz:
https://doaj.org/article/119ed53d7187469e870f090d94a39d4b
Autor:
Alison J. Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Samia Sohail, Alayna Santarosa, Charisse Capadona, Brittney Munayirji, Anita Kumar, Oscar Lahoud, Connie Batlevi, Paul Hamlin, David J. Straus, Colette Owens, Philip Caron, Andrew Intlekofer, Audrey Hamilton, Steven Horwitz, Lorenzo Falchi, William Johnson, Lia Palomba, Ariela Noy, Matthew Matasar, Georgios Pongas, Gilles Salles, Santosha Vardhana, Beatriz Wills Sanin, Joachim Yahalom, Ahmet Dogan, Andrew Zelenetz, Craig H. Moskowitz
Publikováno v:
HemaSphere, Vol 6, Pp 45-46 (2022)
Externí odkaz:
https://doaj.org/article/c3f78da76e2d4f44be43c41df7fd8c16
Autor:
Anita Kumar, Carla Casulo, Erel Joffe, Craig Moskowitz, John Gerecitano, Alison Moskowitz, Anas Younes, Pamela Drullinsky, Esther Drill, Morgan Choma, Clare Grieve, Ashlee Joseph, Leana Laraque, Dylan Schick, Andrew Zelenetz, Paul Hamlin
Publikováno v:
Leukemia & Lymphoma. 63:2889-2896
This study evaluated ofatumumab (Ofa), an anti-CD20 monoclonal antibody, alone or with bendamustine (Benda), in transplant-ineligible patients with mantle cell lymphoma. Low-risk patients received Ofa monotherapy. Non-responders received subsequent t
Autor:
Anthony R. Mato, Meghan Thompson, John N. Allan, Danielle M. Brander, John M. Pagel, Chaitra S. Ujjani, Brian T. Hill, Nicole Lamanna, Frederick Lansigan, Ryan Jacobs, Mazyar Shadman, Alan P. Skarbnik, Jeffrey J. Pu, Paul M. Barr, Alison R. Sehgal, Bruce D. Cheson, Clive S. Zent, Hande H. Tuncer, Stephen J. Schuster, Peter V. Pickens, Nirav N. Shah, Andre Goy, Allison M. Winter, Christine Garcia, Kaitlin Kennard, Krista Isaac, Colleen Dorsey, Lisa M. Gashonia, Arun K. Singavi, Lindsey E. Roeker, Andrew Zelenetz, Annalynn Williams, Christina Howlett, Hanna Weissbrot, Naveed Ali, Sirin Khajavian, Andrea Sitlinger, Eve Tranchito, Joanna Rhodes, Joshua Felsenfeld, Neil Bailey, Bhavisha Patel, Timothy F. Burns, Melissa Yacur, Mansi Malhotra, Jakub Svoboda, Richard R. Furman, Chadi Nabhan
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Venetoclax is a BCL2 inhibitor approved for 17p-deleted relapsed/refractory chronic lymphocytic leukemia with activity following kinase inhibitors. We conducted a multicenter retrospective cohort analysis of patients with chronic lymphocytic leukemia
Externí odkaz:
https://doaj.org/article/cf0cc2d2d3144e71a74d686f011301aa
Autor:
Meghan C. Thompson, Rosemary A. Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, John N. Allan, Martin Šimkovič, Lori Leslie, Joanna Rhodes, Elise A. Chong, Manali Kamdar, Alan Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J. S. Dyer, Harriet S. Walter, Marcus Lefebure, Maria Thadani-Mulero, Michelle Boyer, Juliana Biondo, Kavita Sail, Beenish S. Manzoor, Richard Furman, Kurt S. Bantilan, Andre Goy, Tatyana Feldman, Dominic Labella, Stephen J. Schuster, Jae Park, Lia Palomba, Andrew Zelenetz, Toby A. Eyre, Arnon P. Kater, John F. Seymour, Anthony R. Mato
Publikováno v:
Blood, 6(15), 4553-4557. American Society of Hematology
Blood advances, 6(15), 4553-4557. American Society of Hematology
Thompson, M C, Harrup, R A, Coombs, C C, Roeker, L E, Pu, J J, Choi, M Y, Barr, P M, Allan, J N, Simkovi, M, Leslie, L, Rhodes, J, Chong, E A, Kamdar, M, Skarbnik, A, Lansigan, F, McCall, B, Saja, K, Dyer, M J S, Walter, H S, Lefebure, M, Thadani-Mulero, M, Boyer, M, Biondo, J, Sail, K, Manzoor, B S, Furman, R, Bantilan, K S, Goy, A, Feldman, T, Labella, D, Schuster, S J, Park, J, Palomba, L, Zelenetz, A, Eyre, T A, Kater, A P, Seymour, J F & Mato, A R 2022, ' Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen ', Blood, vol. 6, no. 15, pp. 4553-4557 . https://doi.org/10.1182/bloodadvances.2022007812
Blood advances, 6(15), 4553-4557. American Society of Hematology
Thompson, M C, Harrup, R A, Coombs, C C, Roeker, L E, Pu, J J, Choi, M Y, Barr, P M, Allan, J N, Simkovi, M, Leslie, L, Rhodes, J, Chong, E A, Kamdar, M, Skarbnik, A, Lansigan, F, McCall, B, Saja, K, Dyer, M J S, Walter, H S, Lefebure, M, Thadani-Mulero, M, Boyer, M, Biondo, J, Sail, K, Manzoor, B S, Furman, R, Bantilan, K S, Goy, A, Feldman, T, Labella, D, Schuster, S J, Park, J, Palomba, L, Zelenetz, A, Eyre, T A, Kater, A P, Seymour, J F & Mato, A R 2022, ' Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen ', Blood, vol. 6, no. 15, pp. 4553-4557 . https://doi.org/10.1182/bloodadvances.2022007812
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5788d2dcc76be1604266c786b4beeb47
https://research.vumc.nl/en/publications/dcf1cfe8-7b8c-4df5-b481-6746476ba1c1
https://research.vumc.nl/en/publications/dcf1cfe8-7b8c-4df5-b481-6746476ba1c1
Autor:
William Johnson, Hannah Kalvin, Katherine Panageas, Jasmine Nicodemus, Elizabeth Cathcart, Ya-Hui Lin, Kinga Hosszu, Christina Lee, Paul Hamlin, Steven Horwitz, Andrew Intlekofer, Erel Joffe, Anita Kumar, Connie Batlevi, Matthew Matasar, Alison Moskowitz, Ariela Noy, M Palomba, Gilles Salles, David Straus, Gottfried von Keudell, Andrew Zelenetz, Jaap Jan Boelens, N Babady, Peter Maslak, Jedd D. Wolchok, Santosha Vardhana
Acute SARS-CoV-2 infection results in high mortality rates in patients with cancer with patients dying from a combination of virus and inflammation-driven respiratory failure. We conducted a two-arm, single-institution phase II study of N-acetylcyste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cea2df7220b7c1f87bd5107261d75689
https://doi.org/10.21203/rs.3.rs-1836295/v1
https://doi.org/10.21203/rs.3.rs-1836295/v1
Autor:
Eric Wang, Xiaoli Mi, Meghan C. Thompson, Skye Montoya, Ryan Q. Notti, Jumana Afaghani, Benjamin H. Durham, Alex Penson, Matthew T. Witkowski, Sydney X. Lu, Jessie Bourcier, Simon J. Hogg, Caroline Erickson, Dan Cui, Hana Cho, Michael Singer, Tulasigeri M. Totiger, Sana Chaudhry, Mark Geyer, Alvaro Alencar, Adam J. Linley, M. Lia Palomba, Catherine C. Coombs, Jae H. Park, Andrew Zelenetz, Lindsey Roeker, Mary Rosendahl, Donald E. Tsai, Kevin Ebata, Barbara Brandhuber, David M. Hyman, Iannis Aifantis, Anthony Mato, Justin Taylor, Omar Abdel-Wahab
Publikováno v:
N Engl J Med
BACKGROUND: Covalent (irreversible) Bruton’s tyrosine kinase (BTK) inhibitors have transformed the treatment of multiple B-cell cancers, especially chronic lymphocytic leukemia (CLL). However, resistance can arise through multiple mechanisms, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c7a6941c3658b12d6cb8c107f22ac2
https://europepmc.org/articles/PMC9074143/
https://europepmc.org/articles/PMC9074143/
Autor:
Justin Rendleman, Yevgeniy Antipin, Boris Reva, Christina Adaniel, Jennifer A Przybylo, Ana Dutra-Clarke, Nichole Hansen, Adriana Heguy, Kety Huberman, Laetitia Borsu, Ora Paltiel, Dina Ben-Yehuda, Jennifer R Brown, Arnold S Freedman, Chris Sander, Andrew Zelenetz, Robert J Klein, Yongzhao Shao, Mortimer Lacher, Joseph Vijai, Kenneth Offit, Tomas Kirchhoff
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101685 (2014)
Molecular and genetic evidence suggests that DNA repair pathways may contribute to lymphoma susceptibility. Several studies have examined the association of DNA repair genes with lymphoma risk, but the findings from these reports have been inconsiste
Externí odkaz:
https://doaj.org/article/3f64b33497e7444c8525efdd3f910822